DexCom, Inc. DXCM

Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights

GlobeNewswire Inc. · 5d ago

3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound

Investing.com · 30d ago

Dexcom Scores Pediatric Expansion For OTC Stelo Glucose Monitor

Benzinga · 33d ago

[Latest] Non-Invasive Blood Glucose Monitoring Devices Market Size to Hit USD 340.49 Million with a Promising CAGR of 25.60% by 2034 - Report by Zion Market Research (ZMR)

GlobeNewswire Inc. · 44d ago

Diabetes Tech Player DexCom Lays Out 2030 Growth Vision

Benzinga · 64d ago

Sell in May and Go Away—Starting With These 3 Stocks

Investing.com · 67d ago

9 Stocks That Could Defy the ’Sell in May and Go Away’ Trend This Time

Investing.com · 74d ago

3 Reasons Analysts Love DexCom

Investing.com · 74d ago

Why Medtech Giants Are Quietly Paying Up for AI Diagnostics

Benzinga · 80d ago

Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySens

GlobeNewswire Inc. · 81d ago

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

The Motley Fool · 86d ago

Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom

The Motley Fool · 89d ago

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment

The Motley Fool · 125d ago

Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals

The Motley Fool · 125d ago

2 Growth Stocks to Hold for the Next Decade

The Motley Fool · 130d ago

Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars

The Motley Fool · 143d ago

Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday?

Benzinga · 155d ago

DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights – DXCM

GlobeNewswire Inc. · 204d ago

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

GlobeNewswire Inc. · 204d ago

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. · 204d ago

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. · 207d ago

DexCom, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit

GlobeNewswire Inc. · 214d ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the Firm

GlobeNewswire Inc. · 214d ago

DXCM DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCM

GlobeNewswire Inc. · 214d ago

Portnoy Law Firm Announces Class Action on Behalf of DexCom, Inc. Investors

GlobeNewswire Inc. · 214d ago